ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 5326 - 5340 of 5738 products
Fosun Purchases Another $35 Million of Simcere
$5.00
Available
Anaphore of San Diego Buys RuiYi, a Shanghai Drug Developer
$5.00
Available
Qiagen to Partner with Shanghai Jiao Tong University Lab
$5.00
Available
Lilly Wants to Double China Revenues; Seeks Distribution Partners
$5.00
Available
CSPC Pharma Developing Patented Drugs
$5.00
Available
Sihuan Pharma Doubled its Revenue in 2011
$5.00
Available
Zhejiang Hisoar Given Japanese Approval for Antibiotic
$5.00
Available
Beijing Closes Pharmacies in Two Hospitals
$5.00
Available
Hisun Pharma Diversifies into Animal Health with New Partnership
$5.00
Available
China
$5.00
Available
InflammaGen Begins Clinical Trial of Treatment for Multi-Organ Failure
$5.00
Available
Bayer Seeks $3.3 Billion of China Revenues by 2015
$5.00
Available
Boehringer Ingelheim Plans Shanghai Animal Vaccine R&D Center
$5.00
Available
OriGene Buys Zhongshan Golden Bridge Biotechnology
$5.00
Available
Sihuan Pharma Files IND for New Anti-Hypertensive Drug
$5.00
Available